Sarepta Therapeutics, Inc. (SRPT) Operating income 2016–2025
Sarepta Therapeutics, Inc. (SRPT) annual operating income history from SEC filings — each fiscal year as reported.
-$699.8MFY2025 · since FY2016: -$266.7M → -$699.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$699.8M | -420.9% |
| FY2024 | $218.1M | +181.4% |
| FY2023 | -$267.8M | +50.1% |
| FY2022 | -$536.2M | -16.6% |
| FY2021 | -$459.7M | +18.5% |
| FY2020 | -$564.2M | +20.0% |
| FY2019 | -$705.6M | -105.3% |
| FY2018 | -$343.6M | -100.2% |
| FY2017 | -$171.6M | +35.7% |
| FY2016 | -$266.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice